Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
L3Harris
LHX
|
+$148M |
| 2 |
GE HealthCare
GEHC
|
+$118M |
| 3 |
Atlassian
TEAM
|
+$101M |
| 4 |
Axon Enterprise
AXON
|
+$23.7M |
| 5 |
Reliance Steel & Aluminium
RS
|
+$22.4M |
Top Sells
| 1 |
Apple
AAPL
|
+$360M |
| 2 |
Microsoft
MSFT
|
+$199M |
| 3 |
GE Aerospace
GE
|
+$131M |
| 4 |
NVIDIA
NVDA
|
+$99.2M |
| 5 |
Amazon
AMZN
|
+$85.4M |
Sector Composition
| 1 | Technology | 28.64% |
| 2 | Healthcare | 14.81% |
| 3 | Consumer Discretionary | 11.76% |
| 4 | Industrials | 9.44% |
| 5 | Communication Services | 8.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1151
HUB Group
HUBG
$2.2B
| $5.92M | ﹤0.01% |
141,000
-23,000
| -14% | -$965K |
|
1152
Strategy Inc Common Stock Class A
MSTR
$94B
| $5.9M | ﹤0.01% |
202,000
-23,000
| -10% | -$672K |
|
1153
Interparfums
IPAR
$3.43B
| $5.87M | ﹤0.01% |
41,300
-4,800
| -10% | -$683K |
|
1154
Rapid7
RPD
$1.27B
| $5.87M | ﹤0.01% |
127,800
-14,000
| -10% | -$643K |
|
1155
Otter Tail
OTTR
$3.48B
| $5.85M | ﹤0.01% |
80,900
-9,500
| -11% | -$687K |
|
1156
NewMarket
NEU
$7.87B
| $5.84M | ﹤0.01% |
16,000
-2,100
| -12% | -$766K |
|
1157
Associated Banc-Corp
ASB
$4.35B
| $5.83M | ﹤0.01% |
324,440
-38,500
| -11% | -$692K |
|
1158
Spectrum Brands
SPB
$1.29B
| $5.83M | ﹤0.01% |
87,999
-10,400
| -11% | -$689K |
|
1159
Plexus
PLXS
$3.73B
| $5.82M | ﹤0.01% |
59,700
-7,200
| -11% | -$703K |
|
1160
Coca-Cola Consolidated
COKE
$10.6B
| $5.81M | ﹤0.01% |
108,650
-13,000
| -11% | -$696K |
|
|
BPMC
1161
DELISTED
Blueprint Medicines
BPMC
| $5.81M | ﹤0.01% |
129,100
-15,100
| -10% | -$679K |
|
1162
Cavco Industries
CVCO
$4.32B
| $5.78M | ﹤0.01% |
18,200
-2,200
| -11% | -$699K |
|
1163
Kyndryl
KD
$7.39B
| $5.78M | ﹤0.01% |
391,600
-46,500
| -11% | -$686K |
|
1164
Duolingo
DUOL
$14.1B
| $5.77M | ﹤0.01% |
40,500
-3,800
| -9% | -$542K |
|
1165
Ingevity
NGVT
$2.12B
| $5.77M | ﹤0.01% |
80,690
-11,200
| -12% | -$801K |
|
1166
Ultragenyx Pharmaceutical
RARE
$2.92B
| $5.76M | ﹤0.01% |
143,752
-16,900
| -11% | -$678K |
|
1167
ServisFirst Bancshares
SFBS
$4.57B
| $5.76M | ﹤0.01% |
105,468
-12,500
| -11% | -$683K |
|
1168
Mercury Systems
MRCY
$4.33B
| $5.76M | ﹤0.01% |
112,700
-12,700
| -10% | -$649K |
|
|
AZEK
1169
DELISTED
The AZEK Co
AZEK
| $5.76M | ﹤0.01% |
244,550
-31,400
| -11% | -$739K |
|
1170
COPT Defense Properties
CDP
$3.46B
| $5.75M | ﹤0.01% |
242,700
-28,700
| -11% | -$680K |
|
1171
Resideo Technologies
REZI
$5.66B
| $5.75M | ﹤0.01% |
314,700
-37,000
| -11% | -$676K |
|
1172
Steven Madden
SHOO
$2.26B
| $5.75M | ﹤0.01% |
159,625
-21,600
| -12% | -$778K |
|
1173
Herc Holdings
HRI
$4.2B
| $5.75M | ﹤0.01% |
50,446
-7,300
| -13% | -$831K |
|
|
ARNC
1174
DELISTED
Arconic Corporation
ARNC
| $5.74M | ﹤0.01% |
219,000
-28,900
| -12% | -$758K |
|
1175
Hamilton Lane
HLNE
$6.53B
| $5.74M | ﹤0.01% |
77,600
-7,900
| -9% | -$584K |
|